Carlos Santiago Sanchez MD in Manati, Puerto Rico

Home Puerto Rico Manati

Carlos Santiago Sanchez MD has General Surgery as his primary medical specialty. Their primary office is: Torre Medica I Dr Pedro Blanco in Manati, Puerto Rico. There is an additional office location, for a total of two, for Carlos Santiago Sanchez MD that can be viewed further down. They attended Sorry, his university is not listed and graduated in 1988 (around 36 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Carlos Alberto Santiago Sanchez MD Office Phone and Directions

Carlos Santiago Sanchez MD
Torre Medica I Dr Pedro Blanco
Manati, Puerto Rico 00674
787-784-5706

Patient Ratings
Please rate your experience with Carlos Santiago Sanchez MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 787-784-5706

Enter a starting address:

Healthcare Info for Carlos Santiago Sanchez MD

Medical School: Sorry, his university is not listed
Graduation Year: 1988
The Primary Medical Specialty for Carlos Santiago Sanchez MD is listed as: General Surgery
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 36
PAC (PECOS ID)#: 5991765869
NPI #: 1588646681
NPI Created On: 11/16/2005
NPI Last Updated Listed as: 12/20/2012
Primary Taxonomy Code: 208600000X

URL not found for state: PR licensing board.
License Number:
10298
Listed Gender: Male

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $90

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: Educational Program

Record ID:: 829583863

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular and Metabolism

Name of Drug #1: FARXIGA

Open Associated Drug #1: 0310-6205-30